← Back to headlines
Novo Nordisk Shares Decline Amid Generic Competition and Price Cuts
Novo Nordisk shares have fallen 43% over the past year, largely due to generic rivals forcing the company to implement 48% price cuts on its products.
3 Apr, 16:10 — 3 Apr, 16:10
Sources
Showing 1 of 1 sources
